The number of people with susceptibility test result for rifampicin in Nepal
Nepal: The number of people with susceptibility test result for rifampicin was 81.26 in 2021. ◆ Volatile
Latest (2021)
81.26
Change on year
up 35.6%
World rank
92nd
of 146 countries
All-time high
81.26
in 2021
All-time low
1.3
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Nepal, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Nepal stood at 81.26. That is the highest value across all 5 years on record.
The figure is up 35.6% on the previous year and up 6,142.1% over five years.
Nepal ranks 92nd of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Nepal, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 1.3 | — |
| 2018 | 49.71 | +3718.2% |
| 2019 | 79.81 | +60.6% |
| 2020 | 59.92 | -24.9% |
| 2021 | 81.26 | +35.6% |
Nepal compared with similar countries
- Nepal's 81.26 is above the median for lower middle income countries, which is 78.77, 1.0× the median. (32 countries reporting)
- Nepal's 81.26 is above the median for South Asia, which is 81.26, 1.0× the median. (5 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 43.61 | 1.3 | 79.81 | 3 |
| 2020s | 70.59 | 59.92 | 81.26 | 2 |
Countries ranked near Nepal
More health data for Nepal
- Un projection of annual infant deaths, annual growth rate -1.95 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8518 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,326 deaths per 1,000 people (2090)
- Number of infants who die before age 1 955 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2025)
- Population ages 00-04, female, annual growth rate -1.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0451 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Nepal?
- The number of people with susceptibility test result for rifampicin in Nepal was 81.26 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Nepal?
- The highest recorded value was 81.26 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Nepal?
- The lowest recorded value was 1.3 in 2017.
- How does Nepal rank for the number of people with susceptibility test result for rifampicin?
- Nepal ranks 92nd out of 146 countries with data for 2021.
- Where does this Nepal data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).